|
|
Volumn 11, Issue 7, 2011, Pages 460-
|
|
Leukaemia: Targeted therapy re-enABLed?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BCR ABL PROTEIN;
IMATINIB;
NILOTINIB;
PROTEIN BCL 6;
PROTEIN BCL 6 INHIBITOR;
PROTEIN INHIBITOR;
PROTEIN P21;
PROTEIN P27;
PROTEIN P53;
UNCLASSIFIED DRUG;
ACUTE LYMPHOBLASTIC LEUKEMIA;
CANCER RESISTANCE;
CHRONIC MYELOID LEUKEMIA;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SENSITIVITY;
GENE EXPRESSION;
LEUKEMIA;
MOLECULARLY TARGETED THERAPY;
NOTE;
PRIORITY JOURNAL;
PROMOTER REGION;
SENSITIZATION;
TRANSCRIPTION REGULATION;
UPREGULATION;
|
|
EID: 79959648651
PISSN: 1474175X
EISSN: 14741768
Source Type: Journal
DOI: 10.1038/nrc3099 Document Type: Note |
|
Times cited : (3)
|
|
References (1)
|
